Related Experiment Video
Updated: Jan 8, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
A subspace learning aided matrix factorization for drug repurposing
Amir Mahdi Zhalefar1, Zahra Narimani1
1Department of Computer Science and Information Technology, Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan 45137-66731, Iran.
This study introduces a novel drug repurposing method integrating sparse subspace learning and dual-graph regularization. The approach enhances prediction accuracy and efficiency for identifying new uses for existing drugs.
Area of Science:
- Computational Biology
- Bioinformatics
- Drug Discovery
Background:
- Drug development is costly and time-consuming.
- Machine learning and computational biology offer advanced drug repositioning techniques.
- Improved synergy is needed to enhance predictive accuracy and clinical application.
Purpose of the Study:
- To present a novel approach integrating sparse subspace learning (SLSDR) and a dual-domain drug repurposing method (iDrug).
- To enhance the iDrug objective function using SLSDR for improved feature extraction from drug-disease and drug-target data.
- To develop a holistic solution for optimizing drug repositioning predictions.
Main Methods:
- Integration of SLSDR, a feature selection technique, with the iDrug method for drug repurposing.
- Utilizing matrix factorization for both subspace learning and the iDrug approach.
- Constructing drug-drug, target-target, and disease-disease similarity matrices based on SLSDR-derived features.
- Introducing a novel objective function to capture complex drug-disease interactions.
Main Results:
- The integrated approach offers notable gains in prediction accuracy (AUC, AUPR) and computing efficiency.
- Demonstrated superior performance compared to state-of-the-art drug repurposing methods.
- Preserves data geometry in both feature and sample spaces.
Conclusions:
- The proposed matrix factorization method enhances drug repurposing by integrating drug-disease and drug-target domain knowledge.
- Achieves improved accuracy in drug repurposing compared to existing state-of-the-art methods.
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Predicting Products: Substitution vs. Elimination
The following factors can influence the mechanisms competing against each other:

